RT @EdEsplin: Further evidence, c/w @PedroUson et al. @MayoCancerCare & @Invitae in @CAPR_AACR supporting #universal #germline #genetictest…

RT @EdEsplin: Further evidence, c/w @PedroUson et al. @MayoCancerCare & @Invitae in @CAPR_AACR supporting #universal #germline #genetictest…

Further evidence, c/w @PedroUson et al. @MayoCancerCare & @Invitae in @CAPR_AACR supporting #universal #germline #genetictesting in all #patients w/ #hepatobiliarycancer https://t.co/WaPR2FYEbT #access #reducedisparities #precisionmedicine #precisionth

@HHampel1 @MPishvaian @ShimaghavimiMD Agreed @HHampel1 w/ referral to cancer genetics! https://t.co/epmGDDTgae

RT @CAPR_AACR: #ICYMI: Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospe…

RT @CAPR_AACR: #ICYMI: Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospe…

RT @CAPR_AACR: #ICYMI: Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospe…

#ICYMI: Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study by @PedroUson, Samadder et al. https://t.co/SLfd8QEDM9 https://t.co/pKnhUTHdGL

RT @EdEsplin: ~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM,…

RT @pashtoonkasi: @DucreuxMichel ☝🏽 💡consideration relevant with our colleagues @MayoClinic @MayoCancerCare leading the way, #BRCA 🧬 DNA re…

@DucreuxMichel ☝🏽 💡consideration relevant with our colleagues @MayoClinic @MayoCancerCare leading the way, #BRCA 🧬 DNA repair related aberrations anywhere from 10-25%. Just had a #BRCA2 discussed a Gem/Platinum instead of Cape. Thoughts? Would you give a

RT @EdEsplin: #Germline #genetictesting PGV rate #CRC 15% https://t.co/YE3607PoMk #PancCa 15% https://t.co/yDRbLM25XE #LiverCa 15% https:/…

#Germline #Cancer #Susceptibility Gene Testing in Unselected Patients with #Hepatobiliary Cancers: https://t.co/K4Z7iGaRAz

RT @EdEsplin: #Germline #genetictesting PGV rate #CRC 15% https://t.co/YE3607PoMk #PancCa 15% https://t.co/yDRbLM25XE #LiverCa 15% https:/…

#Germline #genetictesting PGV rate #CRC 15% https://t.co/YE3607PoMk #PancCa 15% https://t.co/yDRbLM25XE #LiverCa 15% https://t.co/o4XivqQqcb #GECancer 15% https://t.co/AbaViHgmQy Universal #germlinetesting for all #patients w/ #GIcancer? @NCCN @CGAIGC @

RT @RHuneburg: @BenWestphalen There are several other papers by the same group on different cancer entities, recently on hepatobiliary canc…

@BenWestphalen There are several other papers by the same group on different cancer entities, recently on hepatobiliary cancers. Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prosp… https://t.

RT @EdEsplin: 1 in 6 #patients with #hepatobiliarycancer have pathogenic #germline mutations. 75% missed by @NCCN. #Genetictesting for all…

RT @EdEsplin: 1 in 6 #patients with #hepatobiliarycancer have pathogenic #germline mutations. 75% missed by @NCCN. #Genetictesting for all…

RT @EdEsplin: 1 in 6 #patients with #hepatobiliarycancer have pathogenic #germline mutations. 75% missed by @NCCN. #Genetictesting for all…

RT @EdEsplin: 1 in 6 #patients with #hepatobiliarycancer have pathogenic #germline mutations. 75% missed by @NCCN. #Genetictesting for all…

1 in 6 #patients with #hepatobiliarycancer have pathogenic #germline mutations. 75% missed by @NCCN. #Genetictesting for all HBC #patients #access #precisiontherapy #clinicaltrials @PedroUson @J_Samadder @MayoClinicCIM @Invitae https://t.co/aoWVYukI6S h

Hepatobiliyer (karaciğer , safra yolu) kanserlerde germline testi, hastaların %15'inden fazlasında kalıtsal mutasyonların saptanmasıyla ilişkilendirilmiştir. #hepatobiliyer kanserli tüm hastalarda germline testi düşünülmelidir. https://t.co/YugKTVRy5s

Germline testing in hepatobiliary cancers was associated with detection of heritable mutations in over 15% of patients (not routinely tested in current guidelines). Germline testing should be considered in all patients with #hepatobiliary cancers. https:

RT @EdEsplin: ~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM,…

RT @EdEsplin: ~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM,…

RT @EdEsplin: ~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM,…

RT @EdEsplin: ~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM,…

RT @EdEsplin: ~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM,…

RT @EdEsplin: ~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM,…

~16% of #cholangiocarcinoma #patients w/ #germline #genetictesting had pathogenic mutations, most in HRR genes (BRCA1/2, ATM, CHEK2, RAD51, etc.) per #INTERCEPT study, @PedroUson @J_Samadder @MayoClinicCIM @Invitae @CAPR_AACR #precisionmedicine https://t.

RT @EdEsplin: 15% of #patients w/ #hepatobiliarycancer had P/LP w/ universal #germline #genetictesting, 75% would be missed by @NCCN guidel…

RT @EdEsplin: 15% of #patients w/ #hepatobiliarycancer had P/LP w/ universal #germline #genetictesting, 75% would be missed by @NCCN guidel…

RT @EdEsplin: 15% of #patients w/ #hepatobiliarycancer had P/LP w/ universal #germline #genetictesting, 75% would be missed by @NCCN guidel…

RT @EdEsplin: 15% of #patients w/ #hepatobiliarycancer had P/LP w/ universal #germline #genetictesting, 75% would be missed by @NCCN guidel…

15% of #patients w/ #hepatobiliarycancer had P/LP w/ universal #germline #genetictesting, 75% would be missed by @NCCN guidelines, 55% eligible for #precisiontherapy/#clinicaltrials #INTERCEPT @PedroUson @J_Samadder @MayoClinicCIM @Invitae @CAPR_AACR ht